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Hepatitis E virus (HEV) is a hepatotropic virus with a single sense-strand RNA genome of ∼7.2 kb in length. Details of the intracellular site of
HEV replication can pave further understanding of HEV biology. In-frame fusion construct of functionally active replicase-enhanced green
fluorescent protein (EGFP) gene was made in eukaryotic expression vector. The functionality of replicase-EGFP fusion protein was established by
its ability to synthesize negative-strand viral RNA in vivo, by strand-specific anchored RT-PCR and molecular beacon binding. Subcellular co-
localization was carried out using organelle specific fluorophores and by immuno-electron microscopy. Fluorescence Resonance Energy Transfer
(FRET) demonstrated the interaction of this protein with the 3′ end of HEV genome. The results show localization of replicase on the endoplasmic
reticulum membranes. The protein regions responsible for membrane localization was predicted and identified by use of deletion mutants.
Endoplasmic reticulum was identified as the site of replicase localization and possible site of replication.
© 2007 Elsevier Inc. All rights reserved.Keywords: Replicase-EGFP; Negative-sense RNA; Molecular beacon; FRET; Endoplasmic reticulumIntroduction
For most positive-strand RNA viruses (both plant and
animal), the replicase or RNA dependent RNA polymerase
(RdRp) localizes to different membranous compartments/
aggresomes and carry out the viral replication at these sites
(Caliguiri and Tamm, 1970; Friedman et al., 1972; De Graaff et
al., 1993; Osman and Buck, 1996; Hwang et al., 1997; Schaad
et al., 1997; Magliano et al., 1998; Kim et al., 1999; Mackenzie
et al., 1999; Pedersen et al., 1999; Schmidt-Mende et al., 2001;
Miller et al., 2001; Wileman, 2006). These membranous
structures or vesicles serve as a platform for the assembly of
various components of replication complex i.e. replicase,
positive-strand RNA genome, other viral and host factors
(Ahlquist et al., 2003). Replication has been implicated to occur
in accordance to the infection specific changes in the ultra-
structure of the membranes (Guinea and Carrasco, 1990; Ahola
et al., 2000). Hence, understanding the underlying mechanism⁎ Corresponding author. Fax: +91 11 26588663.
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basic biology of the virus.
Hepatitis E virus (HEV) infection is the major cause of
enterically transmitted epidemic as well as sporadic hepatitis
globally. The HEV infection is mostly self-limited although a
significant association with acute liver failure has been described
(Hamid et al., 1996; Arora et al., 1996; Acharya et al., 2000). It
has a higher mortality in pregnant women (Khuroo et al., 1981).
Currently, no therapeutics is licensed for HEV (Panda et al.,
2007).
Hepatitis E virus is a 27–34 nm (Tam et al., 1991) icosahedral
particle that contains single stranded-sense RNA of ∼7.2 kb in
length which is capped, polyadenylated and contains three open
reading frames (ORFs) (Panda and Jameel, 1997; Purdy et al.,
1993). It belongs to the family Hepeviridae and genus Hepe-
virus (http://www.ncbi.nlm.nih.gov/8thReportICTV/). The
ORF1 codes for the non-structural polyprotein (pORF1), that
includes methyl-transferase, protease, helicase and replicase.
However, the exact cleavage sites that give rise to individual
functional units are yet to be identified. The polyadenylated 3′
end of the viral RNA binds to the replicase protein to initiate
replication (Agrawal et al., 2001).
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EGFP) from Aequorea victoria (Chalfie et al., 1994) has
revolutionized subcellular localization in live cells as a fusion
partner to many proteins, as it is small (28-kDa) and does not
have any subcellular localization signal of its own. Use of strand
specific molecular beacons has given a tool to localize specific
strands of RNA in vivo (Tyagi and Kramer, 1996). In this report
we describe, the intracellular localization of HEV replicase by
using a functionally active fused reporter (EGFP) construct,
demonstration of its interaction with viral cis-acting elements at
3′ end of the genome and synthesis of negative-sense viral RNA
indicative of replication.
Results
Computer aided analysis of HEV replicase
Earlier observations on sequence homology with other
positive-strand RNA viruses led to the tentative prediction of
the functional domain of replicase in the non-structural
polyprotein of HEV (Koonin et al., 1992). In our previous
study (Agrawal et al., 2001) we used this domain with an
artificial AUG inserted at 3511 nt and expressed in Escherichia
coli as a 63-kDa His-tagged recombinant replicase to study the
in vitro interaction with the 3′ end of positive-sense HEV RNA.
A ∼37-kDa protein was immuno-precipitated with polyclonal
anti-replicase antibody from HEV replicon transfected HepG2
cells (Panda et al., 2000; Thakral et al., 2005). Therefore, the
current study used the first initiation codon (AUG) present at
3913 nt in the predicted domain of replicase that gives a protein
which is more akin to the observed size.
We aligned the amino acid sequence of HEV replicase with
poliovirus polymerase, 3DPol (O'Reilly and Kao, 1998) and
identified the conserved domains predicted to be important for
replicase activity (Fig. 1). These motifs lay between amino acid
positions 1452–1612 of ORF1 protein (Nucleotide positionFig. 1. Sequence alignment of motif A through E of poliovirus and HEVreplicase in th
are shown at the top of each aligned motif sequence. The conserved domains identi
dotted lines: turn and rods: α-helices.4381–4860 of ORF1, GenBank accession no. AF076239). Our
current construct covers the entire domain predicted to be
important for replicase activity (Fig. 1).
Cell line expressing replicase-EGFP fusion protein
To further characterize HEV replicase, the segment nt 3897–
5106 from the full-length infectious clone pSG HEV(I)
(GenBank accession no. AF076239) was used to make in-
frame fusion construct. The fusion construct replicase–EGFP
was made in vector pCDNA3 and uses the natural AUG at
nucleotide position 3913 of pSG HEV(I) (Fig. 2).
Stable transfected cells expressing replicase-EGFP fusion
protein were generated under G418 selection. The resistant
clones were expanded and screened for replicase-EGFP
expression by fluorescence microscopy (Fig. 3A-i), which
showed a perinuclear expression. On the other hand in the
EGFP expressing stable cells, EGFP was distributed throughout
the cell including the nucleus (Fig. 3A-ii). Stable transfected
cells expressing replicase-EGFP were also screened by repli-
case gene specific DNA-PCR/RT-PCR (Fig. 3B). Replicase-
EGFP fusion protein immunoprecipitated as the expected mass
of approximately 68-kDa protein from both transient and stable
transfected cell lines (Fig. 3C-2–4). It had a similar migration
pattern to the in vitro synthesized fusion protein produced by
translation system (Promega) (Fig. 3C-1).
Detection of HEV replication
The functionality of the replicase-EGFP fusion protein
expressed in the stable cell line was assessed by its ability to
synthesize negative-sense HEV RNA. In vitro synthesized
positive-sense HEV transcript 5679–7194A(5) (Fig. 4B-3), was
used as a template to demonstrate synthesis of negative-sense
HEV RNA in the replicase-EGFP expressing stable cells. Stable
transfected cells expressing EGFP alone and normal HepG2e palm domain. Consensus secondary structures as given by Hansen et al. (1997)
fied are predicted to be important for replicase activity. Red arrows: β strands;
Fig. 2. Schematic representation of replicase-EGFP fusion construct in pCDNA3 eukaryotic expression vector. pSG HEV (I) was utilized for gene amplification and
cloning as described in Materials and methods. Numbers represent nucleotide positions in pSG HEV (I) (GenBank accession no. AF076239). pCDNA3-replicase-
EGFP fusion construct was used as a template for making deletion constructs. Presence of boxes in the deletion constructs as compared to pCDNA3-replicase-EGFP
fusion construct denotes presence of that region and absence of the other. The gene of EGFP from modified pEGFP N1 was subcloned in pCDNA3.
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controls.
Strand specific anchored RT-PCR was carried out to detect
the negative-sense as well as the positive-sense strands of
HEV RNA at various time intervals post transfection. Positive-
sense HEV RNA could be detected in transfected HepG2 cells
and in EGFP and replicase-EGFP expressing stable cells at all
time points (Figs. 4C, D). However, negative-sense HEV RNA
could be detected only in replicase expressing stable
transfected cells and not in stable cells expressing EGFP or
HepG2 cells (Figs. 4E, F).
The in vivo negative-sense HEV RNA synthesis was also
confirmed by use of molecular beacon. Molecular beacons are
single-stranded nucleic acid molecules that possess a stem-and-
loop structure (Tyagi and Kramer, 1996). A fluorescent moiety
is attached to one end of the arm (5′ end), and a non-fluorescent
quenching moiety is attached to the other end (3′ end). When
the probe encounters the single-stranded target it forms a hybrid
with the target and undergoes a spontaneous conformational
change that forces the arm sequences, the fluorophore and the
quencher, to separate out facilitating fluorescence to occur. The
molecular beacon designed was a positive-sense HEV oligo
complementary to the negative-sense strand of HEV. It wasstringent enough to be non-complementary to the human
genome.
Positive-sense HEV transcript 5679–7194A(5) was trans-
fected along with the two different molecular beacons: Mb-
6064–6083 and Mb-6181–6200 in separate experiments in to
the replicase-EGFP and EGFP expressing stable cells (Fig. 5).
The Mb-6064–6083 and Mb-6181–6200 were used to detect
HEV negative-sense RNA by confocal microscopy. Fluores-
cence indicative of negative-sense HEV RNA synthesis could
be detected in replicase-EGFP expressing stable cells trans-
fected with positive-sense HEV transcript 5679–7194A(5)
(Figs. 5B-iii–iv, E-iii–iv) but not in the stable cells expressing
EGFP alone (Figs. 5B-i–ii, E-i–ii). Fluorescence could also be
detected in both the replicase-EGFP and EGFP expressing
stable cells, when transfected with negative-sense ORF2
transcript along with the Mb-6064–6083 and Mb-6181–6200
in separate experiments, since negative-sense ORF2 transcript
has the molecular beacon target site and served as a positive
control (Figs. 5A, D). Fluorescence could not be detected in
replicase-EGFP and EGFP expressing stable cells transfected
with unrelated negative-sense fLUC RNA along with the Mb-
6064–6083 and Mb-6181–6200 in separate experiments that
served as a negative control (Figs. 5C, F). These results confirm
Fig. 3. Stable transfected cells expressing replicase-EGFP fusion protein. (A-i) Cytoplasmic expression of replicase-EGFP fusion protein as seen by confocal
microscopy. The nucleus was stained with the nuclear stain DAPI. Scale bar: 10 μm. (A-ii) Expression of EGFP in a stable cell line is seen both in the cytoplasm and
the nucleus by confocal microscopy. Scale bar: 10 μm. (B) Stable transfected cells expressing replicase-EGFP fusion protein tested for the gene of HEV replicase by
DNA-PCR (lanes 2–4) and RT-PCR (lanes 6–8). Molecular size marker (lane 1), negative HepG2 cells (lanes 2 and 6), stable transfected cells expressing HEV
replicase (lanes 3 and 7), mock transfected HepG2 cells (lanes 4 and 8) and no template (lanes 5 and 9). (C) A 68-kDa replicase-EGFP fusion protein after in vitro
translation (lane 1) and immunoprecipitation from transient (lane 2) as well as stable transfected cells (lanes 3 and 4). Mock transfected and immunoprecipitated
HepG2 cells used as control (lane 5). Molecular masses of Rainbow protein marker are indicated to the left and of replicase-EGFP fusion protein to the right, in kDa.
80 S. Rehman et al. / Virology 370 (2008) 77–92that the in vivo expressed replicase-EGFP fusion protein to be
functionally active.
Subcellular co-localization of replicase
We have previously shown cytoplasmic expression of
various HEV proteins (Panda et al., 2000). To extend our
understanding on the subcellular localization of replicase,
pCDNA3-replicase-EGFP described above was transfected
and analyzed in a transient expression system. To study
endoplasmic reticulum (ER) association, pCDNA3-replicase-
EGFP was co-transfected with plasmid pERDsRed2 (Clontech).
pERDsRed2 encodes a fusion protein that consists of the N-
terminal ER targeting sequence of calreticulin and the C-
terminal ER retention sequence, KDEL. Cytoplasmic expres-
sion of replicase-EGFP fusion protein overlapped with the ER
highlighted by ERDsRed2 protein (Fig. 6B-inset). Whereas,
EGFP used as a negative control was distributed throughout the
cell including the nucleus (Fig. 6A).
To further assess the involvement of other membranous
compartments dual-labeling and immunofluorescence analysis
with the antibodies against the Golgi-resident protein GM-130,
and live cell stains for mitochondria (MitoTracker, Molecular
Probes) and lysosomes (LysoTracker, Molecular Probes) were
carried out in separate experiments. Cytoplasmic expression ofreplicase-EGFP fusion protein did not overlap with the staining
of the Golgi apparatus (Fig. 6C-inset). Also, the expression of
replicase-EGFP fusion protein did not overlap with the staining
of lysosomes (Fig. 6D-inset) and mitochondria (Fig. 6E-inset).
EGFP used as a negative control, did not localize with any of
these organelles (Supplementary data).
Prediction of transmembrane domains in replicase and
generation of deletion constructs
The Kyte–Doolittle (Kyte and Doolittle, 1982), the PHDhtm
(Yachdav and Liu, 2003) and TMpred (Hofmann and Stoffel,
1993) methods at www.expasy.org/tools, which function with
the protein databank (PDB), were used for analysis of amino
acid composition of replicase. The Kyte–Doolittle has been
earlier used for the analysis of HEV pORF2 (Zafrullah et al.,
1999) whereas, the PHDhtm and TMpred methods have been
used for the analysis of HCV RdRp (Schmidt-Mende et al.,
2001). Hydropathy profile of replicase showed an average score
of +1.8 U and three regions of peaks above +2.0 U. PHDhtm
(Yachdav and Liu, 2003) used for the prediction of transmem-
brane domains in replicase, identified three transmembrane
sequences in the amino acid region of 1411–1428 aa; 1485–
1502 aa and 1585–1602 aa, whereas, the TMpred program
(Hofmann and Stoffel, 1993) identified two transmembrane
Fig. 4. Detection of HEV replication by strand specific anchored RT-PCR. The negative-sense as well as the sense-strands of HEV RNAwas detected at various time
intervals of 12, 24 and 36 h post transfection. (A) The region 5679–7194 (T)5 of pSG1-HEV (I) was subcloned in pSG to generate pSG 5679–7194 T(5) whereas, HEV
ORF2 and fLUC genes were subcloned in pCDNA3 to give rise to pCDNA3-ORF2 and pCDNA3-fLUC, which were used for in vitro transcription. (B) RNA marker
(lane M), negative-sense fLUC (lane 1) of ∼1.9 kb, negative-sense ORF2 (lane 2) of ∼1.4 kb and positive-sense HEV transcript 5679–7194A(5) of ∼1.5 kb (lane 3).
Positive-sense transcript 5679–7194A(5) was transfected in stable cells expressing replicase-EGFP fusion protein, EGFP expressing stable cells and also in HepG2
cells. (C) Positive-sense HEV RNAwas detected in replicase-EGFP expressing stable cells (lanes 3–5) at all time points. Positive-sense HEV RNA from transfected
HepG2 cells (lanes 6), un-transfected stable cells expressing replicase-EGFP fusion protein (lane 1), minus RT control (lane 2) and 100 bp DNA ladder (lane M). (D)
Positive-sense HEV RNA could be detected in EGFP expressing stable cells (lanes 1–3) at all time points, minus RT control (lane 4), un-transfected stable cells
expressing EGFP (lane 5), and 100 bp DNA ladder (lane M). (E) Negative-sense HEV RNA could be detected only in replicase expressing stable cells transfected with
positive-sense HEV transcript 5679–7194A(5) which increased from 12 h (lane 1), 24 h (lane 2) to 36 h (lane 3) and was not detected in transfected HepG2 cells lacking
HEV replicase (lane 5). Un-transfected stable cells expressing replicase-EGFP fusion protein (lane 6), minus RT control (lane 4) and 100 bp DNA ladder (lane M). (F)
No negative-sense HEV RNA could be detected in EGFP expressing stable cells transfected with positive-sense HEV transcript 5679–7194A(5) at 12 h (lane 1), 24 h
(lane 2) or 36 h (lane 3), minus RT control (lane 4) and un-transfected EGFP expressing stable cells (lane 5), and 100 bp DNA ladder (lane M).
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replicase. These regions were chosen for membrane anchor
analysis.
The transmembrane sequences of 1585–1602 aa was identi-
fied by both these programs and lay between the nucleotideposition of 4780–4837 of HEV genome (GenBank accession no.
AF076239). The other three identified transmembrane sequen-
ces lay between the nucleotide positions of 4228–4534 of HEV
genome (GenBank accession no. AF076239). On the basis of the
identified transmembrane sequences two deletion constructs
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within the construct, pCDNA3-replicase-EGFP (Fig. 2) in a way
that the right frame with the gene of EGFP was retained. In one
deletion construct region from nucleotide position 3913–4526
which covered transmembrane sequences: 1400–1418 aa,
1411–1428 aa and 1485–1502 aa was deleted. Whereas, in the
other, 4449–5109 nt region which covered transmembrane
sequences: 1585–1601 aa was deleted. These deletion con-
structs and pCDNA3-replicase-EGFP were co-transfected with
pERDsRed2 (Clontech) in HepG2 cells, in separate experi-
ments. The deletion construct of replicase-EGFP in which
3913–4526 nt region of replicase was deleted, upon expression
inside transfected HepG2 cells showed a similar ER localization
pattern (Fig. 7B) as observed with the wild type replicase-EGFP
fusion protein (Fig. 7A). Whereas, in the deletion construct of
replicase-EGFP in which the region 4449–5109 nt of replicase
was deleted, upon expression inside transfected HepG2 cells
appeared as aggregates that did not co-localize with the ER
staining (Fig. 7C). This observation suggests that the sequence
for ER localization in replicase is located in the region 4449–
5109 nt as deletion of the region results in the loss of ER
localization.
Interactions of replicase with HEV 3′ end RNA
We have previously shown the in vitro interaction of
replicase with the cis-acting elements present at the 3′ end of
HEV genome is required for its replication (Agrawal et al.,
2001). In this study, the in vivo interaction of replicase with its
3′ cis-acting elements was analyzed in live cells by FRET.
FRET is a non-radiative energy transfer from a donor
fluorophore to an acceptor fluorophore (Periasamy, 2000) and
is a function of the overlap between the emission spectrum of
the donor and the absorption spectrum of the acceptor, quantum
yield of the donor, absorption coefficient for the acceptor and
the relative orientation of the donor and acceptor (Kenworthy,
2001). EGFP and Alexa546 were the FRET pairs. The in vitro
transcribed and Alexa546-UTP labeled HEV 3′ end RNA was
transfected in stable transfected cells expressing replicase-
EGFP fusion protein. FRET efficiency was measured within
12 h of RNA transfection as described under Materials and
methods. Measurements were made by the sensitized emission
approach (Wouters et al., 2001). The areas inside the cell, within
the FRET samples (Figs. 8A, B) where HEV 3′ end RNA co-
localized with replicase-EGFP fusion protein, were taken as a
region of interest (ROIs) and FRET efficiency was calculated
using the LCS Biolab (Leica) software. Over 50 ROIs were
taken for every sample analyzed and FRET efficiency wasFig. 5. Detection of HEV replication by positive-sense molecular beacon complement
with the two different molecular beacons: Mb-6064–6083 (A–C) and Mb-6181–620
stable cells to detect synthesis of HEV negative-sense RNA. Negative-sense HEV OR
show fluorescence from the molecular beacon binding to the target site in the negativ
(iii–iv) expressing stable cells, (B, E) no fluorescence was detected when molecular
expressing stable cells; fluorescence indicative of replication was detected only in rep
with HEV transcript 5679–7194A(5). (C, F) No fluorescence was detected when mole
and replicase-EGFP (iii–iv) expressing stable cells. Images are single representativecalculated. Some of the FRET efficiency values of the various
ROIs are presented in Tables 1A and 1B respectively. As
negative controls we used Alexa-546-UTP labeled mouse β-
actin mRNA transfected in replicase-EGFP expressing cells
(Fig. 8C); and EGFP expressing stable cells transfected with
Alexa-546-UTP labeled positive-sense HEV RNA (Supple-
mentary data) where lack of co-localization was observed. The
FRET formula when tested for EGFP and Alexa546 in the
controls gave abnormally high values, which are considered
“false” FRET values (Supplementary data).
The abnormally high “false” FRET values in the controls can
be attributed to the spectral overlap of EGFP and Alexa546
leading to spectral bleed-through i.e. the FRET signal being
contaminated by donor emission and by the cross excitation of
acceptor molecules by the donor excitation. Possibly, due to the
high expression of EGFP alone and high amounts of Alexa546-
UTP labeled mouse β-actin mRNA in their respective control
cells (Fig. 8C and Supplementary data), the magnitude of cross-
talk or spectral bleed-through was high, which could not be
corrected from the FRET data, and was read out as “false”
FRET. Also, for FRET to occur the two different fluorophores
should be at a distance of the Forster Radius. Forster Radius is
defined as the distance at which the energy transfer is 50%
efficient (Periasamy, 2000). Therefore, FRET efficiency ideally
cannot be more than 50%. Abnormally high “false” FRET
efficiency values were seen in the ROIs in the controls
(Supplementary data) where the two fluorophore did not co-
localize and hence, cannot be taken as the apparent FRET
efficiency. In the test FRET samples, only those regions where
HEV replicase-EGFP and Alexa-546-UTP labeled HEV RNA
co-localized were taken as regions of interest (ROIs), seen as
orange–yellow spots in the superimposed image (Figs. 8A, B)
to calculate FRET efficiency and in these ROIs, FRET
efficiency was never more than 50% and explains for the
apparent FRET between replicase and 3′ end HEV RNA.
Transmission electron microscopy of replicase-EGFP fusion
protein
To verify, corroborate and extend the confocal microscopy
results that demonstrated ER association of replicase, we used
transmission electron microscopy for ultra-structural analysis
by immunogold labeling of replicase-EGFP fusion protein.
Not very abundant but specific labeling was obtained with
rabbit anti-replicase polyclonal antibodies and 20 nm gold
particle labeled secondary antibody. An explanation to this
could be that since cryo-block method was not available,
embedding at 55 °C caused replicase to degrade. Goldary to HEV negative-sense RNA. Different transcripts were co-transfected along
0 (D–F) in separate experiments in to the EGFP and replicase-EGFP expressing
F2 and unrelated fLUC transcripts were included as controls. (A, D) The panels
e-sense ORF2 (served as a positive control) in EGFP (i–ii) and replicase-EGFP
beacon was co-transfected with HEV transcript 5679–7194A(5) in EGFP (i–ii)
licase-EGFP (iii–iv) stable cells when the molecular beacon was co-transfected
cular beacon was co-transfected with unrelated fLUC transcripts in EGFP (i–ii)
confocal sections. Scale bar: 10 μm.
Fig. 6. Subcellular co-localization of replicase. (A) Panel shows distribution pattern of (i) EGFP used as a negative control, (ii) ER labeled with ERDsRed2, (iii)
nucleus stained with DAPI and (iv), its overlay. (B) Panel shows distribution pattern of (i) HEV replicase-EGFP fusion protein, (ii) ER labeled with ERDsRed2, (iii)
nucleus stained with DAPI and (iv), its overlay showing ER localization of HEV replicase. Panels C–E show distribution pattern of (i) HEV replicase-EGFP fusion
protein, (C-ii) Golgi apparatus, (D-ii) lysosomes, (E-ii) mitochondria, (iii) nucleus stained with DAPI and (iv), their respective overlays. Overlays with inset have been
depicted where asterisks show the magnified view. Images are single representative confocal sections. Scale bar: 10 μm.
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iii), which were not observed in HepG2 control cells lacking
HEV replicase (Fig. 9i). These observations are in concor-
dance with our previous observations (Panda et al., 1989),
where involvement of ER with HEV infection was established.Also in an unpublished report by us, in vitro transcribed HEV
RNA of the infectious cDNA clone was used to show
dilatation of the ER and pathology of the cell expressing
pORF2 and pORF3 structural proteins. But none of these
studies used antibodies specific to HEV proteins to show their
Fig. 7. Deletions constructs of HEV replicase (Fig. 2) were co-transfected with pERDsRed2 in HepG2 cells. (A) Panel shows the distribution pattern of (i) replicase-
EGFP fusion protein (ii) ER labeled with ERDsRed2 and (iii) its overlay. (B) Panel shows expression from deletion construct in which 3913–4526 nt region of
replicase was deleted, (ii) ER labeled with ERDsRed2 and (iii) its overlay which showed a similar ER localization pattern as observed with replicase-EGFP fusion
protein (A). (C) Panel shows expression from the deletion construct in which 4449–5109 nt region of replicase was deleted, (ii) ER labeled with ERDsRed2 and (iii) its
overlay, which appeared as aggregates and did not co-localize with ER staining. Overlays with inset have been depicted where asterisks show the magnified view.
Images are single representative confocal sections. Scale bar: 10 μm.
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immunogold labeling showed localization of replicase on the
ER membrane.
Discussion
Formation of a cytoplasmic replication complex that
consists of viral replicase, viral RNA and host cell proteins
on organelle-derived membrane, is required for viral RNA
replication. HEV is a positive-sense RNA virus and belongs to
the large Alphavirus like-superfamily, where replication
proceeds via the negative-sense RNA intermediate (Kaariainen
and Ahola, 2002). Analysis of the intracellular site of
replication and localization of viral proteins has been
technologically a difficult task, particularly so incase of non-
cultivable viruses. The use of confocal microscope and
molecular beacons has helped unravel some of the still unclear
biological phenomena. The current work seeks to understand
the replication of HEV so that its biology is understood better.
In our previous study on HEV reporter replicon, replication
was assessed by its ability to synthesize negative-sense RNA.
No replication could be detected when the replicase domain
in the full-length HEV reporter replicon was deleted (Thakral
et al., 2005).A functional replicase-EGFP fusion protein was expressed
inside the cells, which could synthesize negative-sense HEV
RNA and was detected by strand specific anchored RT-PCR.
The generation of negative-sense HEV RNA was also
confirmed by use of molecular beacon and subsequent detection
of fluorescence by confocal microscopy. The property of
molecular beacons to fluoresce when bound to their targets has
been exploited in HIV (McClernon et al., 2006), HCV (Morandi
et al., 2007) and HBV (Pas et al., 2005) earlier.
Subcellular co-localization of HEV replicase with different
organelle specific probes and antibodies was carried out using
replicase-EGFP fusion construct. We observed ER localization
of replicase both by confocal microscopy and immuno-electron
microscopy. Confocal microscopy with FRET demonstrated the
interaction of HEV replicase with the cis-acting elements at the
3′ end of HEV genome.
Sequence analysis and structure prediction identified
possible transmembrane sequences in replicase, which might
help in its membrane integration. Co-expression analysis of
deletion constructs of HEV replicase with pERDsRed2
showed loss of ER localization when the region 4449–
5109 nt of replicase encoding the predicted transmembrane
sequences was deleted. Amino acid composition analysis of
HEV replicase shows that it is rich in hydrophobic amino
Fig. 8. FRET analysis of HEV replicase and HEV 3′ end RNA. Stable transfected cells expressing replicase-EGFP fusion protein was transfected with Alexa546-UTP
labeled HEV 3′ end viral RNA and mouse β actin mRNA (negative-control). The panels (A, B) represent (i) donor channel, (ii) FRET channel (iii) acceptor channel
and, (iv) superimposed image showing replicase-EGFP fusion protein co-localization with Alexa546-UTP labeled HEV 3′ end viral RNA depicted as orange–yellow
spots. The different regions of interest (ROI) were used for calculating FRET efficiency. FRET efficiency values between replicase and HEV 3′ end RNA for cells
analyzed (panels A and B) are presented in Tables 1A and 1B respectively. The panel (C) represent (i) donor channel, (ii) FRET channel (iii) acceptor channel and, (iv)
superimposed image showing negative control Alexa546-UTP labeled mouse β actin mRNA that did not co-localize with replicase-EGFP fusion protein.
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within the hydrophobic core of the protein, or within the lipid
portion of the membrane. Replicase might be a new member
of the class of tail anchored proteins, but this hypothesis at the
moment requires experimental validation. In contrast with the
classical SRP mediated pathway, tail anchored proteins lack an
NH2-terminal signal sequence, has a targeting signal close to
the C-terminus, which is hydrophobic and forms transmem-
brane domains within the polypeptide that dictates its
membrane integration in an atypical, post-translational man-
ner. It has been reported that for a number of tail anchored
proteins residence in ER requires a short and moderately
hydrophobic anchor (Borgese et al., 2003, Abell et al., 2003,
High and Abell, 2004).Table 1A
FRET efficiency values calculated for the regions of interest (ROIs) presented in Fig.
localized inside the replicase-EGFP expressing stable transfected cells
ROI ROI 1 ROI 2 ROI 4 ROI 5
% Fret efficiency 31 44 38 30Membrane localization has been observed so far, for many
characterized viral replicases. An explanation to the observed
phenomenon could be that membrane localization might serve
as a protective structure by compartmentalizing and sequester-
ing replicase and viral RNA synthesis (Egger et al., 2000) from
host cellular machinery (Ahlquist, 2002). HEV capsid protein,
pORF2 is known to assemble within the ER (Zafrullah et al.,
1999). There has been a report where, functional coupling
between replication and packaging of replicon RNA in
poliovirus (Nugent et al., 1999) has been shown. pORF2
localization in the ER lumen for capsid assembly and ER
membrane localization of replicase, underscores this possibility.
Furthermore, it has been suggested that 5′ end of HEV genome
has the RNA encapsidation signal to which pORF2 binds (Surjit8A, where both replicase and Alexa546-UTP labeled HEV 3′ end viral RNA co-
ROI 6 ROI 7 ROI 11 ROI 17 ROI 19
25 34 48 50 40
Table 1B
FRET efficiency values calculated for the regions of interest (ROIs) presented in Fig. 8B, where both replicase and Alexa546-UTP labeled HEV 3′ end viral RNA co-
localized inside the replicase-EGFP expressing stable transfected cells
ROI ROI 5 ROI 13 ROI 17 ROI 19 ROI 20 ROI 21 ROI 23 ROI 25 ROI 26
% Fret efficiency 14 50 38 10 45 17 37 24 20
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RNA. The proposed model of HEV replication proceeds via a
negative-sense RNA intermediate (Kaariainen and Ahola,
2002). We have shown both by in vitro analysis (Agrawal et
al., 2001) and in the present study by in vivo FRET analysis that
replicase interacts with the 3′ cis-acting elements and synthe-
sizes negative-sense HEV RNA. It is quite convincing to think
that as the HEV positive-sense genomic RNA is being made
from the negative-sense RNA intermediate by the viral replicase,
there could be a simultaneous encapsidation by pORF2 from the
5′ end on the ER.
Severe structural reorganization of ER membrane into
characteristic vesicles is a prominent feature of poliovirus
infection (Egger et al., 2000). Since involvement of ER in HEV
infection (Panda et al., 1989) has been previously identified by
us, it would be interesting to speculate the ultra-structural re-
organization of ER in context to the replicating virus.
Organelle specific targeting of replicase emphasizes on the
specific contributions made by functionally distinct membranesFig. 9. ER localization of replicase by transmission electron microscopy. Panel sho
transfected cells expressing replicase-EGFP fusion protein showed 20 nm gold parti
8900×). Scale bar 0.5 μm. N: nucleus, V: vesicles and ER: endoplasmic reticulum.(Restrepo-Hartwig and Ahlquist, 1996), to the replication
complex and virus exploitation of intrinsic functions associated
with that membrane. Proteins translocate across the ER
membrane through two distinct pathways, one dependent on
signal sequence-signal recognition particle (SRP) and the other
independent of it (Ng et al., 1996). No N-terminal signal
sequences in replicase could be identified with SignalIP version
3.0 (Bendtsen et al., 2004). HEV is a non-enveloped virus, and
may not follow host secretory pathway for its release from the
infected cell. Replicase association with ER is enigmatic,
because ER derived vesicles participate in cellular trafficking.
Analyses of protein translocation across the ER membrane have
shown that along with co-translational mode of protein
translocation mediated by SRP, an alternative or salvage
pathway also exists in absence of SRP (Ng et al., 1996).
HEV replicase localizes to the ER. Earlier observation
suggests that pORF2 localizes to the ER. Hence, their
localization to the ER may be important in linking replication
to nucleo-encapsidation, which requires further investigation.ws (i) negative-control HepG2 cells (magnification 7100×) and (ii–iii) stable
cles indicative of HEV replicase (ii: magnification 7100× and iii: magnification
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Computer aided analysis of HEV replicase
The replicase domain of hepatitis E virus has been predicted
by Koonin et al. (1992). The amino acid sequence of HEV
replicase was aligned with poliovirus polymerase, 3DPol and
conserved domains were identified (O'Reilly and Kao, 1998).
Various proteomics tools: SignalIP version 3.0 (Bendtsen et
al., 2004), Kyte–Doolittle (Kyte and Doolittle, 1982), PHDhtm
(Yachdav and Liu, 2003) and TMpred (Hofmann and Stoffel,
1993) were used to analyze the predicted replicase region.
DNA constructs
For all PCR amplifications and generation of HEV
constructs infectious cDNA clone of pSG1-HEV (I) (GenBank
accession no. AF076239) was utilized. Replicase region 3897–
5106 nt was PCR amplified by forward primer, 3897 nt/FP: 5′
TAT ctc gag ccc ggg CAT GGC CGC CCC GA 3′ and reverse
primer, 5086 nt/RP: 5′ TGT gct agc TTC CAC CCG ACA CAA
GAT TGA 3′ having specific restriction sites. Similarly, 82–
865 nt region of the modified plasmid pEGFP N1 (Clontech)
was PCR amplified by forward primer, 78 nt/FP: 5′ CCA CCG
GTC gct agc ATG GTG AGC AA 3′ and reverse primer, 835 nt/
RP: 5′ CCT CTA CAA AGC TTG TAT GGC TGA TTA TGA
3′. The reverse primer, 5086 nt/RP was modified in a way that
the stop codon in replicase domain was mutated and substituted
by NheI site, which was also present in the 82 nt/FP forward
primer of EGFP. Gene fusion of replicase and EGFP was made
utilizing NheI site such that the right frame was retained. The in-
frame fusion cassette of replicase-EGFP was subcloned into
eukaryotic expression vector pCDNA3 (Invitrogen) to give rise
to pCDNA3-replicase-EGFP fusion construct. The gene of
EGFP was released from modified pEGFP N1 (Clontech) by
BamHI and NotI RE digestions and subcloned in pCDNA3
(Invitrogen). The HindIII-XhoI region of pSG1-HEV (I) was
subcloned in pSG to generate pSG 5679–7194 (T)5. HEV
ORF2 was released from pSG ORF2 which has been earlier
described (Jameel et al., 1996) and subcloned at HindIII and
BamHI RE sites of pCDNA3 (Invitrogen) to give rise to
pCDNA3-ORF2. The gene of firefly lucifersae (fLUC) was
released from the plasmid pGL3-Basic (Promega) and sub-
cloned at HindIII and XbaI RE sites of pCDNA3 (Invitrogen) to
give rise to pCDNA3-fLUC.
pCDNA3-replicase-EGFP was used as a template for making
deletions in the replicase gene in a way that the right frame with
EGFP was retained. The deletion constructs of replicase-EGFP
with deletions covering from nucleotide position 3913–4526 nt
and 4449–5109 nt were produced. All constructs were sequence
confirmed before use.
Cells
Human hepatoma cell line (HepG2), was maintained in
Dulbeco's Modified Eagle's Medium (DMEM, Invitrogen)
supplemented with 10% heat inactivated fetal bovine serum(Invitrogen), 100 U penicillin ml−1, 10 μg streptomycin ml−1
and 25 μg amphotericin B ml−1 (Sigma). Cells were maintained
in an atmosphere with 5% CO2 at 37 °C.
DNA/RNA transfection
ForDNA/RNA transfection and immunofluorescence analysis
2×105 cells seeded onto 22 mm glass-coverslip placed in a
30 mm tissue culture petridish (Linbro), at 60–80% confluence
was used. For RNA transfection followed by total RNA
extraction, 2×106 cells in a 30 mm tissue culture petridish
(Linbro)were used. DNAandRNA transfectionswere carried out
by liposome induction method (Lipofectamine 2000, Invitrogen)
in accordance with the manufacturer's guidelines. For each
30 mm petridish (Linbro) 4 μg column (Qiagen) purified plasmid
and 4 μg of in vitro synthesized RNA (MAXIscript, Ambion)
with 8 μl of Lipofectamine-2000 (Invitrogen) were used.
Generation of geneticin-resistant stable cell line
4 μg of pCDNA3-replicase-EGFP was transfected in
2×106 cells at 60–80% confluence. Geneticin/G418 (Sigma)
at a concentration of 500 μg ml−1 was used for selection and
generation of stable transfected cells as previously described
(Thakral et al., 2005). 80–90% cells exhibiting fluorescence in a
G418-resistant colony when observed under fluorescence
microscope was taken as a positive clone. Total DNA and
RNA was extracted from 2×106 cells using Trizol reagent
(Invitrogen) according to manufacture's instructions and used in
RT-PCR and DNA-PCR with HEV replicase specific primers;
4372 nt/forward: 5′-CGG AAT TCA AAG GCA TCC ATG
GTG TTT GAG AAT GAC-3′ and 4928 nt/reverse: 5′-CGG
GAT CCACACACATCT GAGCTACAT TCG TGAGCT-3′.
Similarly, HepG2 cells were transfected with 4 μg of pCDNA3-
EGFP to generate stable cell line expressing EGFP alone and its
expression was confirmed by fluorescence microscopy.
In vitro coupled transcription-translation and
immunoprecipitation
In vitro synthesis of replicase was carried out using coupled
transcription and translation system (Promega) according to
manufacturer's instructions. Radio-labeling of replicase-EGFP
fusion protein was done with 35S methionine (specific activity
∼1000 Ci/mmol, BRIT, India). Radiolabeled replicase-EGFP
fusion protein from transient and stable transfected cells was
immunoprecipitated as described before (Jameel et al., 1996)
with anti-replicase polyclonal antibody generated in-house.
Immunoprecipitated and in vitro synthesized replicase along
with protein molecular mass standard, Rainbow coloured
protein marker (Amersham) was detected on 10% SDS-PAGE
gel followed by autoradiography.
In vitro transcription and RNA labeling
pSG-5679–7194(T)5 which encodes HEV RNA from
nucleotide position 5679–7194 followed by poly(A)5 residues
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of negative-sense RNA synthesis. pUC18 3′ (+) An as
previously described (Agrawal et al., 2001) encodes HEV 3′
cis acting elements from nucleotide position 7084–7194
followed by poly(A)5 residues. pSG-5679–7194(T)5 and
pUC18 3′ (+) An constructs were digested with XhoI, whereas,
pCDNA3-ORF2 encoding HEV ORF2 and pCDNA3-fLUC
encoding firefly luciferase (fLUC) genes respectively, were
digested with HindIII to produce DNA template for run-off
transcription. The linearized plasmid was phenol-chloroform
extracted, ethanol precipitated and resuspended in 10 μl of
RNase-free water (0.5 μg ml−1). For labeling of RNA during in
vitro transcription reaction, Alexa546-UTP (Molecular Probes)
was used. pTRI β-actin mouse antisense (Ambion) was used to
in vitro transcribe mouse β-actin mRNA. MAXIscript kit
(Ambion) was used for in vitro transcription and Alexa546-
UTP labeling of HEV 3′ end RNA and mouse β-actin mRNA
from a T7 RNA polymerase promoter, in a 20 μl reaction with
0.5 mM rNTPS and 0.05 mM Alexa546-UTP (Molecular
Probes) at 37 °C for 45 min, after which, DNA template was
removed by DNase I (Ambion) treatment at 37 °C for 15 min.
Unincorporated rNTPs clean up from in vitro synthesized RNA,
was done with Nuc Trap (Stratagene) according to manufac-
turer's instruction. MAXIscript kit (Ambion) for unlabeled
reaction was used to in vitro transcribe HEV 5679–7194 (A)5
RNA from T7 RNA polymerase promoter and pCDNA3-ORF2
and pCDNA3-fLUC were in vitro transcribed from SP6 RNA
polymerase promoter to yield negative-sense ORF2 and fLUC
transcripts. In vitro synthesized RNA was phenol-chloroform
extracted, ethanol precipitated and resuspended in RNase-free
water. The integrity was determined on 2% formaldehyde
agarose gel run along with RNA marker (Promega) and
quantitated at 260 nm in a spectrophotometer (Pye-Unicham
8800 UV/VIS Spectrophotometer, Phillips).
Strand-specific anchored RT-PCR
HepG2 cells and stable transfected cells expressing repli-
case-EGFP fusion protein and EGFP were transfected with 4 μg
of HEV transcript 5679–7194 poly(A)5. 2×10
6 cells were
harvested and lysed in Trizol reagent (Invitrogen) at various
time points 12, 24, 36 h post transfection. Total RNA was
isolated by chloroform extraction and 2-propanol precipitation,
followed by 70% ethanol wash. The RNA pellet was air-dried
and re-suspended in diethyl-pyrocarbonate treated water and
quantified spectrophotometrically. For strand-specific anchored
RT-PCR, reverse transcription was carried out with 2 μg of total
cellular RNAwith either forward or reverse primer and 200 U of
Superscript RT-III enzyme (Invitrogen) according to manufac-
ture's instructions.
For negative-sense strand detection RNA was reverse
transcribed with forward primer 5′ Gn=11CCG CGC CCATAC
TTT TGATGA 3′ and for positive-sense strand detection with
the reverse primer 5′GGATTTAGGTGACACTATAGAATC
AGG GAG CGC GGA ACG CAG 3′ as previously described
(Thakral et al., 2005). Appropriate negative controls were
included. The cDNA was used for PCR. For positive-sensestrand, first PCR amplification was carried out using forward: 5′
Gn=11CCG CGC CCA TAC TTT TGA TGA 3′ and reverse: 5′
GGA TTT AGG TGA CAC TAT AGA ATC AGG GAG CGC
GGA ACG CAG 3′ primers. Second amplification was carried
out with inner primers, forward: Poly G primer 5′ GTC GAG
GGGGGGGGGGG 3′ and reverse: primer 5′AGGGAGCGC
GGA ACG CAG AAATGA GAA ATA AGC AAC AGA 3′.
For negative-sense strand, both first and second PCR
amplifications were carried out using forward: Poly G primer
5′ GTC GAG GGG GGG GGG GG 3′ and reverse: 5′ GGA
TTT AGG TGA CAC TAT AGA ATC AGG GAG CGC GGA
ACG CAG 3′ primers.
Molecular beacon
For designing a molecular beacon against the negative-strand
of HEV (GenBank accession no. AF076239) a target sequence
was selected by the software RNA Structure version 4.5
(Mathews et al., 2004), which has the RNA secondary structure
prediction program MFOLD and probe accessibility prediction
program Run OLIGOWALK. In order to find target accessible
sites Soligo program of Sfold (software for statistical folding
and rational design of nucleic acid) was used (Ding et al., 2004).
Positive-sense molecular beacons complementary to HEV
negative-sense RNAwas designed for the region 6064–6083 nt
and 6181–6200 nt (GenBank accession no. AF076239) and
named Mb-6064–6083 and Mb-6181–6200 respectively. It was
custom-made synthesized from Operon Biotechonologies. The
sequence of Mb-6064–6083 was 5′ [BHQ2] GGG TAT GAG
TTT CGC AAC CTT ACC C [AmC7∼Q+ Alexa 546] 3′ and
the sequence of Mb-6181–6200 was 5′ [Cy3] CGC GAT GCT
ACC CGC TTT ATG AAG GTC GCG [BHQ2∼Cy3] 3′. The
molecular beacon was resuspended in 10 mM Tris–EDTA
buffer pH 7.0 to a final concentration of 100 μM. 200 nM of
each Mb-6064–6083 and Mb-6181–6200 were transfected in
separate experiments along with 4 μg of in vitro synthesized
HEV transcript 5679–7194(A)5 in replicase-EGFP and EGFP
expressing stable cells with FuGENE 6 Reagent (Roche)
according to manufacturer's guidelines. Mb-6064–6083 and
Mb-6181–6200 were also transfected separately, along with
negative-sense ORF2 as well as unrelated negative-sense fLUC
RNA in replicase-EGFP and EGFP expressing stable cells, and
served as controls. Cells were fixed with 4% paraformaldehyde
at 12 h post transfection and observed with Leica TCS-SP2
confocal microscope (Leica). Laser lines 488 nm (Ar/Kr VIS)
for EGFP, 543 nm (GrNe VIS) for Alexa546 and Cy3 were
used.
Immunofluorescence assay
Indirect immunofluorescence assay was used to detect
cellular Golgi matrix protein (GM-130) in transfected cells.
Cells were fixed with 4% paraformaldehyde (TAAB) and
methanol permeabilized at −20 °C as described previously
(Tyagi et al., 2004). 1:200 anti GM-130 monoclonal antibody
(BD Pharmingen) were used for primary labeling. For secondary
labeling wavelength specific antibodies, 1:500 donkey anti
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stained with the nuclear stain, 4′ 6-Diamidino-2-phenylindole
(DAPI, Molecular Probes) and observed under a fluorescence
microscope (Nikon Eclipse-600). Images were taken on a Leica
TCS-SP2 confocal microscope (Leica) using 63× oil immer-
sion objective at 512×512 resolution format. Imaging was
performed in a sequential mode and images were processed
using Leica confocal software (LCS, Biolabs) and Adobe
Photoshop version 7.0.
DNA co-transfection with pERDsRed2 and live cell staining
with MitoTracker Deep Red 633 and LysoTracker Red DND 99
For subcellular co-localization, 4 μg of pCDNA3-replicase-
EGFP and different deletion constructs of replicase were
separately co-transfected with 500 ng of pERDsRed2 (Clon-
tech) in HepG2 cells. The, pERDsRed2 transfected alone in
HepG2 cells served as a control. Live cell labeling with 25 nM
MitoTracker and 25 nM LysoTracker, was carried out in
separate experiments. pCDNA3-EGFP used as a control was
similarly analyzed with the organelle specific reporter plasmid
and stains. Transfected HepG2 cells were fixed with 4%
paraformaldehyde at 48 h post transfection, stained with nuclear
stain DAPI and observed with Leica TCS-SP2 confocal
microscope. Laser lines 488 nm (Ar/Kr VIS) for EGFP,
543 nm (GrNe VIS) for DsRed and LysoTracker, 633 nm
(HeNe VIS) for MitoTracker and UV 351 nm and 364 nm for
DAPI excitation were used.
HEV 3′ end RNA transfection and FRET analysis
Stable transfected cells expressing replicase-EGFP fusion
protein were used for RNA transfection and FRET analysis.
2×105 cells seeded onto 22 mm glass-coverslips in a 30 mm
tissue culture petridish (Linbro) at a confluence of 60–80%
were used for transfection with 4 μg of Alexa546-UTP labeled
RNA and 8 μl of Lipofectamine-2000 (Invitrogen). Replicase-
EGFP fusion protein expressing stable cells were taken as donor
reference sample, Alexa546-UTP labeled HEV 3′ end RNA
transfected HepG2 cells as acceptor reference sample, and
replicase-EGFP fusion protein expressing stable cells trans-
fected with Alexa546-UTP labeled HEV 3′ end RNA were
taken as the test FRET sample. For negative-control: replicase-
EGFP fusion protein expressing stable cells were taken as donor
reference sample, Alexa546-UTP labeled mouse β-actin
mRNA transfected HepG2 cells as acceptor reference and
replicase-EGFP fusion protein expressing stable cells trans-
fected with Alexa546-UTP labeled mouse β-actin mRNA was
taken as the negative FRETsample. EGFP expressing cells were
also included in the control group. EGFP expressing stable cells
were taken as donor reference sample, Alexa546-UTP labeled
HEV 3′ end RNA transfected HepG2 cells as acceptor reference
sample, and EGFP expressing stable cells transfected with
Alexa546-UTP labeled HEV 3′ end RNA were taken as
negative FRET sample (Supplementary data). FRET analysis
was performed in live cells 12 h post RNA transfection. A
planapo 63×numerical aperture/1.4 oil immersion objectiveand 512×512 resolution format of Leica TCS-SP2 confocal
microscope was used. Laser lines 488 nm for EGFP and 543 nm
for Alexa546 excitation were used. FRET was detected using
sensitised emission approach and guidelines of the LCS Biolabs
(Leica) software were followed. Energy transfer from the EGFP
donor channel, to Alexa546 the acceptor channel, was read as
emission of Alexa546 at 577±30 nm recorded in the FRET
channel. Calibration of the images from: donor, acceptor and
FRET samples, was carried out post imaging with the LCS
Biolabs (Leica) software. Over 50 regions of interest (ROIs)
were taken for every cell analyzed and apparent FRET
efficiency expressed in percentage was calculated with the
formula as described before (van Rheenen et al., 2004).
Transmission electron microscopy
Stable transfected cells expressing replicase-EGFP fusion
protein and HepG2 cells lacking replicase were fixed in 0.8%
glutaraldehyde and 2% paraformaldehyde made in 0.1 M
sodium phosphate buffer pH 7.2 for 3 h, dehydrated in graded
series of ethanol (30%, 50%, 70%, 90% and absolute alcohol)
with 30 min incubation at 4 °C each time. Infiltration of the cells
was carried out with LR resin (London Resin Company) and
blocks were prepared by embedding at 55 °C. 70 nm sections
were cut on an Ultracut E (Reichert), placed on grid (nickel,
300 nmmesh), blocked with 2% skimmed milk, immunostained
with rabbit anti-replicase polyclonal antibodies and 20 nm-gold-
labeled anti rabbit secondary antibody (TAAB), counterstained
with aqueous uranyl acetate (BDH) and analyzed by 100 KV
Philips Morgagni 268 D (TEM) transmission electron micro-
scopy (Fei).
Acknowledgments
This work was supported by Grant-in-Aid from the
Department of Science and Technology (DST), Government
of India, to Prof. Subrat Kumar Panda. Shagufta Rehman and
Neeraj Kapur are recipients of fellowship from the Council of
Scientific and Industrial Research (CSIR), Government of
India.
We gratefully acknowledge AIIMS electron microscopy
facility and the efforts of Dr. Taposh K. Das (EM facility,
Department of Anatomy, AIIMS) for his assistance and
helpful discussions. We sincerely acknowledge Anil Kundalia
(Labindia, India) and Dr. Susanne Liebe (Leica Microsys-
tems, Germany) for their constant support and assistance with
Leica confocal microscope and helping us with the FRET
experiment.
References
Abell, B.M., Jung, M., Oliver, J.D., Knight, B.C., Tyedmers, J., Zimmermann,
R., High, S., 2003. Tail-anchored and signal-anchored proteins utilize
overlapping pathways during membrane insertion. J. Biol. Chem. 278,
5669–5678.
Acharya, S.K., Panda, S.K., Saxena, A., Gupta, S.D., 2000. Acute hepatic
failure in India: a perspective from the East. J. Gastroenterol. Hepatol. 15,
473–479.
91S. Rehman et al. / Virology 370 (2008) 77–92Agrawal, S., Gupta, D., Panda, S.K., 2001. The 3′ end of hepatitis E virus (HEV)
genome binds specifically to the viral RNA-dependent RNA polymerase
(replicase). Virology 282, 87–101.
Ahlquist, P., 2002. RNA-dependent RNA polymerases, viruses, and RNA
silencing. Science 296, 1270–1273.
Ahlquist, P., Noueiry, A.O., Lee, W.M., Kushner, D.B., Dye, B.T., 2003. Host
factors in positive-strand RNA virus genome replication. J. Virol. 15,
8181–8186.
Ahola, T., Kujala, P., Tuittila, M., Blom, T., Laakkonen, P., Hinkkanen, A.,
Auvinen, P., 2000. Effects of palmitoylation of replicase protein nsP1 on
alphavirus infection. J. Virol. 74, 6725–6733.
Arora, N.K., Nanda, S.K., Gulati, S., Ansari, I.H., Chawla, M.K., Gupta, S.D.,
Panda, S.K., 1996. Acute viral hepatitis types E, A, and B singly and in
combination in acute liver failure in children in north India. J. Med. Virol.
48, 215–221.
Bendtsen, J.D., Nielsen, H., von Heijne, G., Brunak, S., 2004. Improved
prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340, 783–795.
Borgese, N., Colombo, S., Pedrazzini, E., 2003. The tale of tail-anchored
proteins: coming from the cytosol and looking for a membrane. J. Cell Biol.
161, 1013–1019.
Caliguiri, L.A., Tamm, I., 1970. The role of cytoplasmic membranes in
poliovirus biosynthesis. Virology 42, 100–111.
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., Prasher, D.C., 1994. Green
fluorescent protein as a marker for gene expression. Science 263, 802–805.
De Graaff, M., Coscoy, L., Jaspars, E.M., 1993. Localization and biochemical
characterization of alfalfa mosaic virus replication complexes. Virology 194,
878–881.
Ding, Y., Chan, C.Y., Lawrence, C.E., 2004. Sfold web server for statistical
folding and rational design of nucleic acids. Nucleic Acids Res. 32,
W135–W141 (Web Server issue).
Egger, D., Teterina, N., Ehrenfeld, E., Bienz, K., 2000. Formation of the
poliovirus replication complex requires coupled viral translation, vesicle
production, and viral RNA synthesis. J. Virol. 74, 6570–6580.
Friedman, R.M., Levin, J.G., Grimley, P.M., Berezesky, I.K., 1972. Membrane-
associated replication complex in arbovirus infection. J. Virol. 10, 504–515.
Guinea, R., Carrasco, L., 1990. Phospholipid biosynthesis and poliovirus
genome replication, two coupled phenomena. EMBO J. 9, 2011–2016.
Hamid, S.S., Jafri, S.M., Khan, H., Shah, H., Abbas, Z., Fields, H., 1996.
Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral
hepatitis? J. Hepatol. 25, 20–27.
Hansen, J.L., Long, A.M., Schultz, S.C., 1997. Structure of the RNA-dependent
RNA polymerase of poliovirus. Structure 5, 1109–1122.
High, S., Abell, B.M., 2004. Tail-anchored protein biosynthesis at the
endoplasmic reticulum: the same but different. Biochem. Soc. Trans. 32,
659–662.
Hofmann, K., Stoffel, W., 1993. TMbase—A database of membrane spanning
proteins segments. Biol. Chem. Hoppe-Seyler 374, 166.
Hwang, S.B., Park, K.J., Kim, Y.S., Sung, Y.C., Lai, M.M., 1997. Hepatitis C
virus NS5B protein is a membrane-associated phosphoprotein with a
predominantly perinuclear localization. Virology 227, 439–446.
Jameel, S., Zafrullah, M., Ozdener, M.H., Panda, S.K., 1996. Expression in
animal cells and characterization of the hepatitis E virus structural proteins.
J. Virol. 70, 207–216.
Kaariainen, L., Ahola, T., 2002. Functions of alphavirus nonstructural proteins
in RNA replication. Prog. Nucleic Acid Res. Mol. Biol. 71, 187–222.
Kenworthy, A.K., 2001. Imaging protein–protein interactions using fluores-
cence resonance energy transfer microscopy. Methods 24, 289–296.
Khuroo, M.S., Teli, M.R., Skidmore, S., Sofi, M.A., Khuroo, M.I., 1981.
Incidence and severity of viral hepatitis in pregnancy. Am. J. Med. 70,
252–255.
Kim, J.E., Song, W.K., Chung, K.M., Back, S.H., Jang, S.K., 1999. Subcellular
localization of hepatitis C viral proteins in mammalian cells. Arch. Virol.
144, 329–343.
Koonin, E.V., Gorbalenya, A.E., Purdy, M.A., Rozanov, M.N., Reyes, G.R.,
Bradley, D.W., 1992. Computer-assisted assignment of functional domains
in the nonstructural polyprotein of hepatitis E virus: delineation of an
additional group of positive-strand RNA plant and animal viruses. Proc.
Natl. Acad. Sci. U. S. A. 89, 8259–8263.Kyte, J., Doolittle, R.F., 1982. A simple method for displaying the hydropathic
character of a protein. J. Mol. Biol. 157, 105.
Mackenzie, J.M., Jones, M.K., Westaway, E.G., 1999. Markers for trans-Golgi
membranes and the intermediate compartment localize to induced
membranes with distinct replication functions in flavivirus-infected cells.
J. Virol. 73, 9555–9567.
Magliano, D., Marshall, J.A., Bowden, D.S., Vardaxis, N., Meanger, J., Lee,
J.Y., 1998. Rubella virus replication complexes are virus-modified
lysosomes. Virology 240, 57–63.
Mathews, D.H., Disney, M.D., Childs, J.L., Schroeder, S.J., Zuker, M., Turner,
D.H., 2004. Incorporating chemical modification constraints into a dynamic
programming algorithm for prediction of RNA secondary structure. Proc.
Natl. Acad. Sci. U. S. A. 101, 7287–7292.
McClernon, D.R., Vavro, C., St. Clair, M., 2006. Evaluation of a real-time
nucleic acid sequence-based amplification assay using molecular beacons
for detection of human immunodeficiency virus type 1. J. Clin. Microbiol.
44, 2280–2282.
Miller, D.J., Schwartz, M.D., Ahlquist, P., 2001. Flock house virus RNA
replicates on outer mitochondrial membranes in Drosophila cells. J. Virol.
75, 11664–11676.
Morandi, L., Ferrari, D., Lombardo, C., Pession, A., Tallini, G., 2007.
Monitoring HCV RNA viral load by locked nucleic acid molecular beacons
real timePCR. J. Virol. Methods 140, 148–154.
Ng, D.T., Brown, J.D., Walter, P., 1996. Signal sequences specify the
targeting route to the endoplasmic reticulum membrane. J. Cell Biol. 134,
269–278.
Nugent, C.I., Johnson, K.L., Sarnow, P., Kirkegaard, K., 1999. Functional
coupling between replication and packaging of poliovirus replicon RNA.
J. Virol. 73, 427–435.
O'Reilly, E.L., Kao, C.C., 1998. Analysis of RNA-dependent RNA
polymerase structure and function as guided by known polymerase
structures and computer predictions of secondary structure. Virology 252,
287–303.
Osman, T.A., Buck, K.W., 1996. Complete replication in vitro of tobacco
mosaic virus RNA by a template-dependent, membrane-bound RNA
polymerase. J. Virol. 70, 6227–6234.
Panda, S.K., Jameel, S., 1997. Hepatitis E virus: from epidemiology to
molecular biology. Viral Hepat. Rev. 3, 227–251.
Panda, S.K., Datta, R., Kaur, J., Zuckerman, A.J., Nayak, N.C., 1989.
Enterically transmitted non-A, non-B hepatitis: recovery of virus-like
particles from an epidemic in south Delhi and transmission studies in rhesus
monkeys. Hepatology 10, 466–472.
Panda, S.K., Ansari, I.H., Durgapal, H., Agrawal, S., Jameel, S., 2000. The in
vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious.
J. Virol. 74, 2430–2437.
Panda, S.K., Thakral, D., Rehman, S., 2007. Hepatitis E virus. Rev. Med. Virol.
17, 151–180.
Pas, S.D., Noppornpanth, S., van der Eijk, A.A., de Man, R.A., Niesters, H.G.,
2005. Quantification of the newly detected lamivudine resistant YSDD
variants of Hepatitis B virus using molecular beacons. J. Clin. Virol. 32,
166–172.
Pedersen, K.W., van der Meer, Y., Roos, N., Snijder, E.J., 1999. Open reading
frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic
reticulum-derived double-membrane vesicles which carry the viral replica-
tion complex. J. Virol. 73, 2016–2026.
Periasamy, A., 2000. Fluorescence resonance energy transfer microscopy a mini
review. J. Biomed. Opt. 6, 287–291.
Purdy, M.A., Tam, A.W., Huang, C.C., Yarbough, P.O., Reyes, G.R., 1993.
Hepatitis E virus: a non-enveloped member of the ‘alpha-like’ RNA virus
supergroup. Semin. Virol. 4, 319–326.
Restrepo-Hartwig, M.A., Ahlquist, P., 1996. Brome mosaic virus helicase- and
polymerase-like proteins colocalize on the endoplasmic reticulum at sites of
viral RNA synthesis. J. Virol. 70, 8908–8916.
Schaad, M.C., Jensen, P.E., Carrington, J.C., 1997. Formation of plant RNA
virus replication complexes on membranes: role of an endoplasmic
reticulum-targeted viral protein. EMBO J. 16, 4049–4059.
Schmidt-Mende, J., Bieck, E., Hugle, T., Penin, F., Rice, C.M., Blum, H.E.,
Moradpour, D., 2001. Determinants for membrane association of the
92 S. Rehman et al. / Virology 370 (2008) 77–92hepatitis C virus RNA-dependent RNA polymerase. J. Biol. Chem. 276,
44052–44063.
Surjit, M., Jameel, S., Lal, S.K., 2004. The ORF2 protein of hepatitis E virus
binds the 5′ region of viral RNA. J. Virol. 78, 320–328.
Tam, A.W., Smith, M.M., Guerra, M.E., Huang, C.-C., Bradley, D.W., Fry, K.E.,
Reyes, G.R., 1991. Hepatitis E virus (HEV): molecular cloning and
sequencing of the full-length viral genome. Virology 185, 120–131.
Thakral, D., Nayak, B., Rehman, S., Durgapal, H., Panda, S.K., 2005.
Replication of a recombinant hepatitis E virus genome tagged with reporter
genes and generation of a short-term cell line producing viral RNA and
proteins. J. Gen. Virol. 86, 1189–1200.
Tyagi, S., Kramer, F.R., 1996. Molecular beacons: probes that fluoresce upon
hybridization. Nat. Biotechnol. 14, 303–308.
Tyagi, S., Surjit, M., Roy, A.K., Jameel, S., Lal, S.K., 2004. The ORF3 protein
of hepatitis E virus interacts with liver-specific alpha1-microglobulin and itsprecursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites
their export from the hepatocyte. J. Biol. Chem. 279, 29308–29319.
van Rheenen, J., Langeslag, M., Jalink, K., 2004. Correcting confocal
acquisition to optimize imaging of fluorescence resonance energy transfer
by sensitized emission. Biophys. J. 86, 1–13.
Wileman, T., 2006. Aggresomes and autophagy generate sites for virus
replication. Science 312, 875–878.
Wouters, F.S., Verveer, P.J., Bastiaens, P.I., 2001. Imaging biochemistry inside
cells. Trends Cell Biol. 11, 203–211.
Yachdav, G., Liu, J., 2003. The PredictProtein Server. Nucleic Acid Res. 32,
W321–W326 (Web Server issue).
Zafrullah, M., Ozdener, M.H., Kumar, R., Panda, S.K., Jameel, S., 1999.
Mutational analysis of glycosylation, membrane translocation, and cell
surface expression of the hepatitis E virus ORF2 protein. J. Virol. 73,
4074–4082.
